Randomized, Controlled Trial of TNF-α Antagonist in CTL-mediated Severe Cutaneous Adverse Reactions

Journal of Clinical Investigation - United States
doi 10.1172/jci93349
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

Severe Cutaneous Adverse Reactions

2013English

Recent Advances in the Understanding of Severe Cutaneous Adverse Reactions

British Journal of Dermatology
DermatologyMedicine
2017English

Cyclosporine - An Eye Opener in Severe Cutaneous Adverse Drug Reactions

IP Indian Journal of Clinical and Experimental Dermatology
2018English

Identification of Drug-Specific Public TCR Driving Severe Cutaneous Adverse Reactions

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2019English

Pharmacogenomics of Severe Cutaneous Adverse Reactions and Drug-Induced Liver Injury

Journal of Human Genetics
Genetics
2013English

Mechanisms of Severe Cutaneous Adverse Reactions and a New Treatment Strategy

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2019English

Severe Adverse Reactions Prompt Call for Trial Design Changes

BMJ
2006English

Drug-Induced Severe Cutaneous Adverse Reactions (SCARs): Determine the Cause and Prevention

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Severe Cutaneous Adverse Reactions: A 4-Year Experience in a Tertiary Referral Hospital in Malaysia

International Journal of Family & Community Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy